Member Info for John117

I’ve sold all my other shares to go all in here. Bought at 26p today to max out. It looks like a seller is suppressing the SP, but that cannot last.

I agree, it’s a matter of when

And the Americans will see the New York Times

I can’t believe it either. On Sky news tonight though. Great advert.

SNG

Synairgen just been on Sky news, loads of coverage elsewhere today too.

You might regret selling today dude

.

We will no doubt. I don’t know how this isn’t double today. Tiny market cap and a very promising drug that could help the whole planet. Maybe it will take a few days before people get it.

http://www.pmlive.com/pharma_news/uk_biotech_synairgen_to_begin_covid-19_trial_of_lead_candidate_1329470?SQ_DESIGN_NAME=2&

http://www.pmlive.com/pharma_news/uk_biotech_synairgen_to_begin_covid-19_trial_of_lead_candidate_1329470?SQ_DESIGN_NAME=2&

.

But at the end of the day it works by boosting the lungs immune response to virus. The potential is massive. The Mcap is tiny.

.

This is massive

Couldn’t agree more.

Lots of infrastructure projects to come, hospitals etc. Sit tight people.

Sounds like an antibody test, which are different to PCR. One doesn’t replace the other. The important difference, as far as my understanding goes, is a PCR tells you where you are now, whereas an antibody test is window on the past. Our bodies don’t produce antibodies straight away after being infected. They are complementary to each other

“For those that we believe have been exposed, for those who are showing symptoms, we’ve been able to provide the testing,” Pence said.

He went on to say the US "distributed 1,500 kits, with roughly 500 tests each so there’s roughly about a million and a half tests going out to hospitals."

Because you don’t inject people with drugs that are not thoroughly tested unless you are talking about Ebola with a 7 out of 10 death rate. Then it’s worth the risk. But COVID-19, as scary as it seams, is maximum 3 out of 100 (personally think it will end up at 0.5%}. The death rate is simply not high enough to risk taking experimental drugs. Fact.